Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 5/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.46 |
| ▸ | GPR3 | P46089 | 1/20 | 0.46 |
| ▸ | RAC1 | P63000 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 4/20 | 0.42 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | TERT | O14746 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | STAT3 | P40763 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7823188 | 0.87 | ADORA3 (0.47) | CYP2A6GPR3RAC1ALDH1A1HSD17B10 | |
| SCHEMBL11361354 | 0.87 | ADORA3 (0.52) | CYP2A6CYP1A2ALDH1A1HIF1AHPGD | |
| SCHEMBL11361585 | 0.87 | CCR1 (0.57) | CYP2A6CYP1A2GPR3RAC1ALDH1A1 | |
| SCHEMBL31197184 | 0.84 | ALDH1A1 (0.54) | CYP2A6CYP1A2ALDH1A1HSD17B10HPGD | |
| SCHEMBL30112574 | 0.84 | ALDH1A1 (0.51) | CYP2A6CYP1A2RAC1ALDH1A1HPGD | |
| SCHEMBL30112644 | 0.81 | TP53 (0.48) | RAC1ALDH1A1HPGDKDM4ETDP1 | |
| SCHEMBL27992753 | 0.81 | RAC1 (0.46) | RAC1ALDH1A1HPGDKDM4EGAA | |
| SCHEMBL30112646 | 0.81 | CYP19A1 (0.47) | RAC1ALDH1A1HPGDKDM4ETDP1 | |
| SCHEMBL637928 | 0.81 | CYP2A6 (0.50) | CYP2A6CYP1A2GPR3ALDH1A1HSD17B10 | |
| SCHEMBL19009532 | 0.80 | MEN1 (0.54) | RAC1ALDH1A1HPGDKDM4ETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105294776-A | Method for preparing symmetric dimer of nitrogen heterocyclic ring aromatic compound | UNIV LANZHOU | 2016-02-03 | — | — | CN | disclosed |
| US-9236613-B2 | Cyclic compound, its metal complex and modified metal complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-01-12 | — | — | US | disclosed |
| US-9236613-B2 | Cyclic compound, its metal complex and modified metal complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-01-12 | — | — | US | disclosed |
| US-9130233-B2 | Metal complex, modified compound thereof and useful compound thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-09-08 | — | — | US | disclosed |
| US-9130233-B2 | Metal complex, modified compound thereof and useful compound thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-09-08 | — | — | US | disclosed |
| EP-2239263-B1 | CYCLIC COMPOUND, ITS METAL COMPLEX, AND MODIFIED METAL COMPLEX | SUMITOMO CHEMICAL CO (JP) | 2014-01-15 | — | — | EP | disclosed |
| US-8546291-B2 | Cyclic compound, its metal complex and modified metal complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-10-01 | — | — | US | disclosed |
| US-8546291-B2 | Cyclic compound, its metal complex and modified metal complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-10-01 | — | — | US | disclosed |
| US-20130210615-A1 | METAL COMPLEX, MODIFIED COMPOUND THEREOF AND USEFUL COMPOUND THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-08-15 | — | — | US | disclosed |
| US-20130210615-A1 | METAL COMPLEX, MODIFIED COMPOUND THEREOF AND USEFUL COMPOUND THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-08-15 | — | — | US | disclosed |
| EP-1308452-B1 | Oligonucleotide labeling reactants based on acyclonucleosides and conjugates derived thereof | WALLAC OY (FI) | 2008-03-19 | — | — | EP | disclosed |
| US-7282581-B2 | Oligonucleotide labeling reactants based on acyclonucleosides and conjugates derived thereof | WALLAC OY (FI) | 2007-10-16 | — | — | US | disclosed |
| US-7282581-B2 | Oligonucleotide labeling reactants based on acyclonucleosides and conjugates derived thereof | WALLAC OY (FI) | 2007-10-16 | — | — | US | disclosed |
| US-7279233-B2 | Light-emitting material and light-emitting device | CANON KABUSHIKI KAISHA (JP) | 2007-10-09 | — | — | US | disclosed |
| US-7279233-B2 | Light-emitting material and light-emitting device | CANON KABUSHIKI KAISHA (JP) | 2007-10-09 | — | — | US | disclosed |
| US-5432101-A | Complex consists of biologically active molecule associated by coupling or adsorption with the complex | COMPAGNIE ORIS INDUSTRIE SA (FR) | 1995-07-11 | — | — | US | disclosed |
| US-5220012-A | Macropolycyclic rare earth complexes and application as fluorescent tracers | COMPAGNIE ORIS INDUSTRIE SA (FR) | 1993-06-15 | — | — | US | disclosed |
| EP-0180492-B1 | MACROPOLYCYCLIC COMPLEXES OF RARE EARTH METALS AND APPLICATION AS FLUORESCENT LABELS | CIS BIO INTERNATIONAL (FR) | 1993-06-02 | — | — | EP | disclosed |
| US-4927923-A | IMMUNOLOGY | COMPAGNIE ORIS INDUSTRIES (FR) | 1990-05-22 | — | — | US | disclosed |
| EP-0180492-A1 | Macropolycyclic complexes of rare earth metals and application as fluorescent labels | CIS BIO INTERNATIONAL (FR) | 1986-05-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130210615-A1 | METAL COMPLEX, MODIFIED COMPOUND THEREOF AND USEFUL COMPOUND THEREOF | C5, PRMT1, C1QBP | CYP2A6 1393/4885CYP1A2 682/4885GPR3 3333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.